If an API process is confidential and is described in a master file, how should the API producer deal with informing customers of a process change?

However, Section 13 says, “current dosage form manufacturers should be notified of changes
from established production and process control procedures that can affect the quality of the
API”. So the expectation is that drug product customers should be notified of any changes that
could affect API quality.